# Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.

> **NCT03050983** · — · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 440 (actual)

## Conditions studied

- Respiratory Depression
- Respiratory Insufficiency

## Interventions

- **DEVICE:** IPI

## Key facts

- **NCT ID:** NCT03050983
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2018-01-26
- **Final completion:** 2020-09-10
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2020-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03050983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03050983, "Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03050983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*